The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus

References

• Zhang Y, Sun X, Icli B, et al. Emerging roles for MicroRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev. 2017;38(2):145–168. doi:10.1210/er.2016-1122
   PubMed Web of Science ®Google Scholar
• Cole J, Florez J. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5
   PubMed Web of Science ®Google Scholar
• Solomon S, Chew E, Duh E, et al. Diabetic retinopathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(3):412–418. doi:10.2337/dc16-2641
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Aldington S, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337–347. doi:10.1016/S2213-8587(19)30411-5
   PubMed Web of Science ®Google Scholar
• Sabanayagam C, Banu R, Chee M, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabete Endocrinol. 2019;7(2):140–149. doi:10.1016/S2213-8587(18)30128-1
   PubMed Web of Science ®Google Scholar
• The Lancet Diabetes Endocrinology. Under the lens: diabetic retinopathy. Lancet Diabetes Endocrinol. 2020;8(11):869. doi:10.1016/S2213-8587(20)30347-8
   Web of Science ®Google Scholar
• Schorr S, Hammes H, Müller U, et al. The prevention and treatment of retinal complications in diabetes. Dtsch Arztebl Int. 2016;113(48):816–823. doi:10.3238/arztebl.2016.0816
   Web of Science ®Google Scholar
• Ahlqvist E, Van Zuydam N, Groop L, et al. The genetics of diabetic complications. Nat Rev Nephrol. 2015;11(5):277–287. doi:10.1038/nrneph.2015.37
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung CMG, Larsen M, et al. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16030. doi:10.1038/nrdp.2016.30
   Web of Science ®Google Scholar
• Ding Y, Zhao J, Liu G, et al. Total bilirubin predicts severe progression of diabetic retinopathy and the possible causal mechanism. J Diabetes Res. 2020;2020:7219852. doi:10.1155/2020/7219852
   Web of Science ®Google Scholar
• Forrester J, Kuffova L, Delibegovic M. The role of inflammation in diabetic retinopathy. Front Immunol. 2020;11:583687. doi:10.3389/fimmu.2020.583687
   PubMed Web of Science ®Google Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33. doi:10.1016/j.lfs.2017.12.001
   PubMed Web of Science ®Google Scholar
• Spencer B, Estevez J, Liu E, et al. Pericytes, inflammation, and diabetic retinopathy. Inflammopharmacology. 2020;28(3):697–709. doi:10.1007/s10787-019-00647-9
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aurora R, Siswanto B, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 2022;33(2):137–143. doi:10.1097/MCA.0000000000001040
   PubMed Web of Science ®Google Scholar
• Fu W, Fu H, Ye W, et al. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: a meta-analysis. Int Immunopharmacol. 2021;101:108235. doi:10.1016/j.intimp.2021.108235
   Web of Science ®Google Scholar
• Gemenetzis G, Bagante F, Griffin J, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266(2):339–345. doi:10.1097/SLA.0000000000001988
   Web of Science ®Google Scholar
• Patel A, Ravaud A, Motzer R, et al. Neutrophil-to-lymphocyte ratio as a prognostic factor of disease-free survival in postnephrectomy high-risk locoregional renal cell carcinoma: analysis of the S-TRAC trial. Clin Cancer Res. 2020;26(18):4863–4868. doi:10.1158/1078-0432.CCR-20-0704
   PubMed Web of Science ®Google Scholar
• Liang T, Chen J, Xu G, et al. Platelet-to-lymphocyte ratio as an independent factor was associated with the severity of ankylosing spondylitis. Front Immunol. 2021;12:760214. doi:10.3389/fimmu.2021.760214
   Web of Science ®Google Scholar
• Erre G, Paliogiannis P, Castagna F, et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. 2019;49(1):e13037. doi:10.1111/eci.13037
   PubMed Web of Science ®Google Scholar
• Liu D, Czigany Z, Heij L, et al. The value of platelet-to-lymphocyte ratio as a prognostic marker in cholangiocarcinoma: a systematic review and meta-analysis. Cancers. 2022;14:2.
   Web of Science ®Google Scholar
• Yu Y, Wang L, Cao S, et al. Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation. Transl Lung Cancer Res. 2020;9(6):2315–2327. doi:10.21037/tlcr-20-666
   Web of Science ®Google Scholar
• Chen L, Liu C, Liang T, et al. Monocyte-to-lymphocyte ratio was an independent factor of the severity of spinal tuberculosis. Oxid Med Cell Longev. 2022;2022:7340330. doi:10.1155/2022/7340330
   PubMed Web of Science ®Google Scholar
• Jakubowska K, Koda M, grudzińska M, et al. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients. World J Gastroenterol. 2020;26(31):4639–4655. doi:10.3748/wjg.v26.i31.4639
   PubMed Web of Science ®Google Scholar
• Liu J, Liu X, Li Y, et al. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. Biosci Rep. 2018;38:3. doi:10.1042/BSR20180172
   Web of Science ®Google Scholar
• Verdoia M, Schaffer A, Barbieri L, et al. Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. Diabetes Metab. 2015;41(4):304–311. doi:10.1016/j.diabet.2015.01.001
   Web of Science ®Google Scholar
• Duman T, Aktas G, Atak B, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–1606. doi:10.4314/ahs.v19i1.35
   PubMed Web of Science ®Google Scholar
• Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria World Health Organization. Diabetes Res Clin Pract. 1999;44(1):21–26. doi:10.1016/S0168-8227(99)00008-X
   PubMed Web of Science ®Google Scholar
• Wilkinson C, Ferris F, Klein R, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Defronzo R, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. doi:10.1038/nrdp.2015.19
   PubMed Web of Science ®Google Scholar
• Kang Q, Yang CJ. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799. doi:10.1016/j.redox.2020.101799
   PubMed Web of Science ®Google Scholar
• Wu M, Yiang G, Lai T, et al. The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med Cell Longev. 2018;2018:3420187. doi:10.1155/2018/3420187
   PubMed Web of Science ®Google Scholar
• Li C, Miao X, Li F, et al. Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy. Oxid Med Cell Longev. 2017;2017:9702820. doi:10.1155/2017/9702820
   PubMed Web of Science ®Google Scholar
• Bokhary K, Aljaser F, Abudawood M, et al. Role of oxidative stress and severity of diabetic retinopathy in type 1 and type 2 diabetes. Ophthalmic Res. 2021;64(4):613–621. doi:10.1159/000514722
   PubMed Web of Science ®Google Scholar
• Semeraro F, Morescalchi F, Cancarini A, et al. Diabetic retinopathy, a vascular and inflammatory disease: therapeutic implications. Diabetes Metab. 2019;45(6):517–527. doi:10.1016/j.diabet.2019.04.002
   PubMed Web of Science ®Google Scholar
• Chen J, Tan W. Platelet activation and immune response in diabetic microangiopathy. Clin Chim Acta. 2020;507:242–247. doi:10.1016/j.cca.2020.04.042
   PubMed Web of Science ®Google Scholar
• Nwadiugwu M. Inflammatory activities in type 2 diabetes patients with co-morbid angiopathies and exploring beneficial interventions: a systematic review. Public Health Front. 2020;8:600427. doi:10.3389/fpubh.2020.600427
   Google Scholar
• Rohm T, Meier D, Olefsky J, et al. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55. doi:10.1016/j.immuni.2021.12.013
   PubMed Web of Science ®Google Scholar
• Kocak M, Aktas G, Atak B, et al. Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50(3):e13206. doi:10.1111/eci.13206
   PubMed Web of Science ®Google Scholar
• Bilgin S, Kurtkulagi O, Atak Tel B, et al. Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes Mellitus? Care Time Study. 2021;15(6):1071–1074.
   Google Scholar
• Wang X, Antony V, Wang Y, et al. Pattern recognition receptor-mediated inflammation in diabetic vascular complications. Med Res Rev. 2020;40(6):2466–2484. doi:10.1002/med.21711
   PubMed Web of Science ®Google Scholar
• Pauline HE, Gaucher D. Diabetic retinopathy. Rev Prat. 2017;67(9):1001–1008.
   Google Scholar
• Rübsam A, Parikh S, Fort P. Role of inflammation in diabetic retinopathy. International journal of molecular sciences. Int J Mol Sci. 2018;19:4. doi:10.3390/ijms19040942
   Web of Science ®Google Scholar
• Hattori Y, Hashizume K, Nakajima K, et al. The effect of long-term treatment with sulindac on the progression of diabetic retinopathy. Curr Med Res Opin. 2007;23(8):1913–1917. doi:10.1185/030079907X218770
   PubMed Web of Science ®Google Scholar
• Atak B, Aktas G, Duman TT, et al. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 2019;65(1):38–42. doi:10.1590/1806-9282.65.1.38
   PubMed Web of Science ®Google Scholar
• Huang X, Yang S, Zhao Q, et al. Predictive value of non-high-density lipoprotein cholesterol and neutrophil-lymphocyte ratio for coronary artery vulnerable plaques in type 2 diabetes mellitus. Front Cardiovasc Med. 2022;9:927768. doi:10.3389/fcvm.2022.927768
   PubMed Web of Science ®Google Scholar
• Azab B, Daoud J, Naeem FB, et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail. 2012;34(5):571–576. doi:10.3109/0886022X.2012.668741
   PubMed Web of Science ®Google Scholar
• Jaaban M, Zetoune AB, Hesenow S, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. doi:10.1016/j.heliyon.2021.e07564
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio As a predictor of diabetic kidney injury in type 2 diabetes mellitus; The MADKID Study. J Diabetes Metab Disord. 2020;19(2):997–1002. doi:10.1007/s40200-020-00595-0
   PubMed Web of Science ®Google Scholar
• Ulu S, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15(11):942–947. doi:10.1089/dia.2013.0097
   PubMed Web of Science ®Google Scholar
• Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009–10019. doi:10.3390/ijerph120810009
   PubMed Web of Science ®Google Scholar
• Wang J, Chen Z, Yang K, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55. doi:10.1186/s13098-020-00562-y
   PubMed Web of Science ®Google Scholar
• Luo W, Zhang W. The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a Meta-analysis and systematic review. Int J Ophthalmol. 2019;12(2):312–323. doi:10.18240/ijo.2019.02.20
   Web of Science ®Google Scholar